Holen Sie sich die Stockscreener-App
100.62
1.41%
1.40
Handel nachbörslich:
100.31
-0.31
-0.31%
Schlusskurs vom Vortag:
$99.22
Offen:
$98.71
24-Stunden-Volumen:
7.12M
Relative Volume:
1.04
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.09%
1M Leistung:
+3.19%
6M Leistung:
+11.82%
1J Leistung:
+40.81%
1-Tages-Spanne:
$98.20
$100.63
1-Wochen-Bereich:
$96.84
$100.63
52-Wochen-Spanne:
$64.99
$103.52
Spdr Biotech Etf Stock (XBI) Company Profile
Firmenname
Spdr Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Spdr Biotech Etf Aktie (XBI) Neueste Nachrichten
(XBI) Investment Analysis and Advice - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
Best Biotech ETFs to Watch Right Now - The Motley Fool
XBI: Biotech ETF Is A Must Have (NYSEARCA:XBI) - Seeking Alpha
(XBI) Technical Pivots with Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
Biotech and Retail ETFs have the highest implied call return, according to Goldman - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
8 Charts Suggesting Stock Market Pullback Could Deepen in the Near-Term - Investing.com
How To Trade (XBI) - Stock Traders Daily
7 Best-Performing Biotech ETFs for October 2024 - NerdWallet
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
6 Best Health Care ETFs to Buy Now | Investing - U.S News & World Report Money
SPDR Bloomberg Short Term High Yield Bond ETF (NYSEARCA:SJNK) Reaches New 1-Year High at $25.74 - Defense World
Biotech IPOs return as sector recovers after funding overhang - Seeking Alpha
Where are the Opportunities in (XBI) - Stock Traders Daily
(09/26/24) BCYC: A Promising Play in the Biotech Sector - Moneyshow.com
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MSN
XBI Is Breaking Out And Likely To Outperform In The Near Term (Technical Analysis) - Seeking Alpha
Objective long/short (XBI) Report - Stock Traders Daily
Why Biotech ETFs Are Beating the Market - TradingView
Biotech Stocks Look Ready to Rally - Barron's
Biotech stocks poised for a comeback as interest rates fall - ShareCafe
Biotech Stocks Are Showing Signs of Life. Why the Rally Could Continue. - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
3 Biotech ETFs for a Diversified Portfolio - Inkl
IBB: 3 Biotech ETFs for a Diversified Portfolio - StockNews.com
2 Biotech Stocks to Buy Hand Over Fist in August - MSN
Mather Group LLC. Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
(XBI) Trading Report - Stock Traders Daily
2 Biotech Stocks Making Moves Today - Schaeffers Research
Form 424B2 BofA Finance LLC - StreetInsider.com
3 Biotech Names With Potential Catalysts By Year End - Seeking Alpha
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why. - sharewise
Osaic Holdings Inc. Acquires 179 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech ETF (XBI) rallied from the blue box hitting target - FXStreet
Biotech ETF (XBI) Rallied From The Blue Box Hitting Target - Barchart
TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail
Biotech ETF (XBI) Rallied from the Blue Box Hitting Target - Barchart
TSX 60 ESG Index (TSXE) QuotePress Release - The Globe and Mail
Kingsview Wealth Management LLC Purchases 127 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Banco Santander S.A. - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Avantax Advisory Services Inc. - Defense World
Finanzdaten der Spdr Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für Spdr Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):